Recession Signal As Consumers Struggle To Pay Bills

Novo Nordisk Extends Slide After Announcing Price-Cuts For Blockbuster Obesity Drugs Novo Nordisk shares in Copenhagen can't catch a bid. The liquidation is accelerating again after a Bloomberg headline on Tuesday morning: the Danish drugmaker will slash U.S. list prices for Wegovy and Ozempic next year. The move suggests that the new CEO is pursuing market share amid intensifying competition in the GLP-1 space. Jamey Millar, Novo's head of U.S. operations, was quoted by Bloomberg as saying the company set a monthly price of $675 for its family of semaglutide drugs,...

Cantor Fitzgerald Slammed Over Tariff Trades Which Never Happened In retrospect, if only Cantor Fitzgerald was called PolyCantor, none of this would have happened. Ever since September, the upstart online betting marketplace PolyMarket has been offering traders the opportunity to make money by betting whether the US Supreme Court would rule in favor or against Trump's tariffs, with millions of bets placed for either outcome (of course, we learned the outcome at 10am ET on Friday, when a 6-3 majority - including two Justices selected by Trump - voted against the...